A large, long-term study led by an Albert Einstein College of Medicine researcher has found that the introduction of the ...
A study found that the introduction of human papillomavirus vaccine in community settings is highly effective in protecting ...
The first vaccines, approved in 2006, protects against four strains, HPV-6, HPV-11, HPV-16 and HPV-18. Another, approved in ...
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present four abstracts at the 2025 American Society for Radiation Oncology Annual ...
At ASTRO, Artera presented clinical validation data on its prostate cancer test in an Asian population,and showed how the test may complement gene expression-based approaches.
Adding neoadjuvant and adjuvant pembrolizumab to the standard of care significantly improved event-free survival in patients with previously untreated, locally advanced head and neck squamous cell ...
Two new exploratory studies of radioenhancers used in combination with radiation therapy in the treatment of head and neck cancers showed that these agents can boost the effectiveness of radiotherapy ...
The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinoma.
BUFFALO, N.Y. — On Tuesday, Roswell Park Comprehensive Cancer Center celebrated the reopening of one of its cancer treatment centers following an expansion. The Head & Neck Surgery, Plastic Surgery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback